Inhibition of intestinal motility by anandamide, an endogenous cannabinoid

Author： Calignano A.   La Rana G.   Makriyannis A.   Lin S.Y.   Beltrano M.   Piomelli D.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.340, Iss.2, 1997-12, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs

By Stengel P.W.   Rippy M.K.   Cockerham S.L.   Devane W.A.   Silbaugh S.A.  

European Journal of Pharmacology, Vol. 355, Iss. 1, 1998-08 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats

By Izzo A.A.   Mascolo N.   Pinto L.   Capasso R.   Capasso F.  

European Journal of Pharmacology, Vol. 384, Iss. 1, 1999-11 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca 2+ fluxes in rabbit T-tubule membranes

By Oz M.   Tchugunova Y.B.   Dunn S.M.J.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 13-20

Elsevier

Access to resources Recommend Favorite

Relationship between Cannabinoid CB1 and Dopamine D2 Receptors in Intestinal Motility in Mice

By Carai M.A.M.   Agabio R.   Lobina C.   Pani M.   Reali R.   Vacca G.   Colombo G.   Gessa G.L.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 287-291

Pharmaceutical Press

Access to resources Recommend Favorite

Anandamide: an endogenous activator of the vanilloid receptor

By Smart D.   Jerman J.C.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 134-134

Elsevier

Access to resources Recommend Favorite